A panel of experts, including Meenakshi Jolly, MD, MS, will discuss various issues involved in the management and treatment of lupus patients, including comorbidities that affect lupus patients and how to monitor for them, the role of patient-reported outcomes, and the factors that contribute to treatment adherence in lupus patients.
Valora Gurganious, MBA, CHBC, has spent decades helping clients understand the business side of their practice. Her session will help attendees navigate the strategies and concepts that can help build a practice that is as successful financially as it is clinically.
Participation in a Qualified Clinical Data Registry (QCDR) such as the RISE Registry allows participants to meet quality reporting requirements through a seamless reporting process.
The Rheumatology Research Foundation is offering the latest in the Rodnan Commemorative Gout Print series for sale this year at the ACR Discovery
The ACR’s Committee on Research put together an exceptional cadre of medical experts in a variety of disciplines who were part of the ACR’s Basic Research Conference and Clinical Research Conference on Friday and Saturday.
In addition to the support provided for the 2016 ACR/ARHP Annual Meeting, the ACR, the ARHP, and the Foundation wish to thank the following organizations for providing support for activities and programs throughout the year.
“Some clinicians know about the JAK inhibitors, but it’s new to many,” said John O’Shea, MD. “The first member of this class, tofacitinib, was approved in 2012, but it’s a very fast-moving field with multiple new agents being studied.”
Everything about the way you practice rheumatology changes on Jan. 1, 2017. “We will have to re-evaluate the practice of rheumatology to adapt to upcoming changes in our compensation,” said Douglas Graham, MD.
Noah Wolcott Palm, PhD, Assistant Professor of Immunobiology and a member of the Human and Translational Immunology Program at Yale University School of Medicine, said that a large amount of microbiota-profiling data has been accumulated in the six years that microbiome sessions have been held at the Annual Meeting.
Luke O’Neill, PhD, will explore the converging worlds of inflammation and metabolism during a State-of-the-Art Lecture on Immuno-Metabolism: Energetics and Inflammation.